Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2021Bioorganic ChemistryOpen Access

Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJustyna GodyńPZPaula ZarębaDŁDorota Łażewska

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Godyń et al. (2021) studied this question.

synapsesocial.com/papers/6ab365f84ddda921142bc877https://doi.org/10.1016/j.bioorg.2021.105129
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade2018 · 299 citations
  2. 2100 Years of Alzheimer's disease (1906–2006)2006 · 49 citations